[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1985

News and Notes

Arch Dermatol. 1985;121(6):722. doi:10.1001/archderm.1985.01660060034016

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

GRISACTIN ULTRA (GRISEOFULVIN ULTRAMICROSIZE) (125, 250, 330 mg tablets) BRIEF SUMMARY (For full prescribing information, see package circular.) GRISACTIN Ultra Brand of griseofulvin ultramicrosize A Fungistatic Antibiotic INDICATIONS: Griseofulvin is indicated for the treatment of ringworm infections of the skin, hair, and nails, namely: Tinea corporis, Tinea pedis, Tinea cruris, Tinea barbae, Tinea capitis. Tinea unguium (onychomycosis) when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum, Epidermophyton floccosum. NOTE: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of this drug is not justified in minor or trivial infections which will respond to topical agents alone. Griseofulvin is not effective in the following: Bacterial infections, Candidiasis (Moniliasis), Histoplasmosis, Actinomycosis, Sporotrichosis, Chromoblastomycosis, Coccidioidomycosis, North American

First Page Preview View Large
First page PDF preview
First page PDF preview
×